NCT01238939View on ClinicalTrials.gov

Study of NK012 and 5-FU/LV in Solid Tumors Followed by Dose Expansion in Colorectal Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

December 31, 2013

Study Completion Date

March 31, 2014

Conditions
Advanced Solid TumorsMetastatic Colorectal Cancer
Interventions
DRUG

NK012 and 5-FU

NK012 infusion on Day 1 of each 28 day cycle 5-FU continuous infusion on Days 1 and 15 of each 28 day cycle

Trial Locations (1)

Unknown

Sarah Cannon Research Institute, Nashville

Sponsors
All Listed Sponsors
lead

Nippon Kayaku Co., Ltd.

INDUSTRY

NCT01238939 - Study of NK012 and 5-FU/LV in Solid Tumors Followed by Dose Expansion in Colorectal Cancer | Biotech Hunter | Biotech Hunter